Chris Cabell, senior vice president and head of the Therapeutic & Specialty Business Development team at Quintiles, discusses the challenges emerging biopharma companies face while bringing a drug to market and how choosing the right development partner can help alleviate the pressures of securing technology solutions, global experience, and talent, to focus on developing their molecule.